Cargando…

Risk of atrial fibrillation in patients with pneumoconiosis: A nationwide study in Taiwan

BACKGROUND: To investigate the incidence of new‐onset atrial fibrillation (AF) among subjects with pneumoconiosis using the Taiwan National Health Insurance Research Database. HYPOTHESIS: Pneumoconiosis patients are at an increased risk of AF. METHODS: A total of 12 209 pneumoconiosis patients were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Wei‐Syun, Lin, Cheng‐Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2019
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954379/ https://www.ncbi.nlm.nih.gov/pubmed/31785026 http://dx.doi.org/10.1002/clc.23290

Ejemplares similares

Bidirectional association between aortic dissection and atrial fibrillation: Findings from a huge national database
por: Hu, Wei‐Syun, et al.
Publicado: (2019)

Cholangitis in patients with atrial fibrillation: A retrospective cohort study in Taiwan
por: Hu, Wei-Syun, et al.
Publicado: (2022)

Acupuncture decreases risk of stroke among patients with atrial fibrillation: A nationwide investigation
por: Hu, Wei-Syun, et al.
Publicado: (2022)

Risk of Atrial Fibrillation in Patients with Congenital Heart Disease: Results of a Propensity Score-Matched, Nationwide Cohort Study
por: Hu, Wei-Syun, et al.
Publicado: (2019)

Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan
por: Chang, Chia-Yu, et al.
Publicado: (2017)

Risk of pneumothorax in pneumoconiosis patients in Taiwan: a retrospective cohort study
por: Pan, Jo-Hui, et al.
Publicado: (2021)

Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study
por: Zhang, Zhuxin, et al.
Publicado: (2021)

Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High‐risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation (STUDY‐AF)
por: Turakhia, Mintu P., et al.
Publicado: (2015)

Impact of atrial fibrillation on the development of ischemic stroke among cancer patients classified by CHA(2)DS(2)-VASc score-a nationwide cohort study
por: Hu, Wei-Syun, et al.
Publicado: (2018)

Predictive value of HMGB1 for atrial fibrillation recurrence after cryoballoon ablation in paroxysmal atrial fibrillation patients
por: Li, Xinxin, et al.
Publicado: (2022)

Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter
por: Hu, Wei-Syun, et al.
Publicado: (2020)

Atrial fibrillation catheter ablation complications in obese and diabetic patients: Insights from the US Nationwide Inpatient Sample 2005–2013
por: D'Souza, Shawn, et al.
Publicado: (2021)

Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation
por: Simon, Judit, et al.
Publicado: (2021)

Initial rivaroxaban dosing in patients with atrial fibrillation
por: Ablefoni, Kaja, et al.
Publicado: (2019)

Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan
por: Chan, Yi-Hsin, et al.
Publicado: (2022)

Atrioventricular block can be used as a risk predictor of clinical atrial fibrillation
por: Zhao, Xiao, et al.
Publicado: (2019)

Diabetes and atrial fibrillation in hospitalized patients in the United States
por: Kumar, Nilay, et al.
Publicado: (2021)

6‐year change in high sensitivity cardiac troponin T and the risk of atrial fibrillation in the Atherosclerosis Risk in Communities cohort
por: Li, Linzi, et al.
Publicado: (2021)

NT Pro‐BNP can be used as a risk predictor of clinical atrial fibrillation with or without left atrial enlargement
por: Zhao, Xiao, et al.
Publicado: (2021)

Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation
por: Yosefy, Chaim, et al.
Publicado: (2019)

Safety and efficacy of ablation for atrial fibrillation in combination with left atrial appendage occlusion in octogenarians
por: Zhang, Peng‐Pai, et al.
Publicado: (2023)

N‐terminal pro‐B‐type natriuretic peptide and D‐dimer combined with left atrial diameter to predict the risk of ischemic stroke in nonvalvular atrial fibrillation
por: Shen, Zican, et al.
Publicado: (2022)

The risk of suicide in patients with critical illness: A population-based study in Taiwan
por: Hu, Wei-Syun, et al.
Publicado: (2022)

Safety and efficacy of catheter ablation in atrial fibrillation patients with left ventricular dysfunction
por: Long, Songbing, et al.
Publicado: (2019)

Use of oral anticoagulants and its associated factors among nonvalvular atrial fibrillation patients with new‐onset acute ischemic stroke: A report from the China Atrial Fibrillation Registry study
por: Wang, Jing‐Rong, et al.
Publicado: (2021)

Impact of left atrial appendage fibrosis on atrial fibrillation in patients following coronary bypass surgery
por: Eckstein, Jan, et al.
Publicado: (2022)

Type of atrial fibrillation and outcomes in patients without oral anticoagulants
por: Ren, Jiameng, et al.
Publicado: (2020)

Assessing left atrial function in patients with atrial fibrillation and valvular heart disease using cardiovascular magnetic resonance imaging
por: Hou, Jie, et al.
Publicado: (2022)

Charcoal maker's pneumoconiosis
por: Watanabe, Hiroki, et al.
Publicado: (2022)

Expression of miRNAs in plasma exosomes derived from patients with atrial fibrillation
por: Wei, Zhang, et al.
Publicado: (2020)

Death of a child and the risk of atrial fibrillation: a nationwide cohort study in Sweden
por: Wei, Dang, et al.
Publicado: (2021)

The predictive value of a concise classification of left atrial appendage morphology to thrombosis in non‐valvular atrial fibrillation patients
por: He, Jionghong, et al.
Publicado: (2020)

Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: Results from the National Tunisian Registry of Atrial Fibrillation (NATURE‐AF)
por: Ouali, Sana, et al.
Publicado: (2021)

Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real‐world prospective study
por: Camm, A. John, et al.
Publicado: (2020)

Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study
por: Gómez Doblas, Juan José, et al.
Publicado: (2023)

Left atrial activation and asymmetric anatomical remodeling in patients with atrial fibrillation: The relation between anatomy and function
por: Nedios, Sotirios, et al.
Publicado: (2020)

Pneumoconiosis increases the risk of congestive heart failure: A nationwide population-based cohort study
por: Yen, Chia-Ming, et al.
Publicado: (2016)

Continuous monitoring of sleep‐disordered breathing with pacemakers: Indexes for risk stratification of atrial fibrillation and risk of stroke
por: Mazza, Andrea, et al.
Publicado: (2020)

Impact of age on thromboembolic events in patients with non‐valvular atrial fibrillation
por: Kim, Yun Gi, et al.
Publicado: (2019)

Association of psychosocial factors with all‐cause hospitalizations in patients with atrial fibrillation
por: Meyre, Pascal B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1as9k7fpne7o3fk1cc77covnoh